PPT-Supplemental figure 1 PD-L2 (

Author : eleanor | Published Date : 2022-06-18

fpkm PDL1 fpkm CD8 fpkm Iba1 fpkm p lt 0001 p lt 0001 p lt 0001 p lt 0001 GMCSF GMCSF GMCSF GMCSF Supplemental Figure 1 Gene expression analysis in breast

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Supplemental figure 1 PD-L2 (" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Supplemental figure 1 PD-L2 (: Transcript


fpkm PDL1 fpkm CD8 fpkm Iba1 fpkm p lt 0001 p lt 0001 p lt 0001 p lt 0001 GMCSF GMCSF GMCSF GMCSF Supplemental Figure 1 Gene expression analysis in breast cancer cases from TCGA database Gene expression levels of CD8 Iba1 PDL1 and PDL2 in breast cancer were compared between the cases with and without GMCSF expression The MannWhitney . Linda Beebe. June 2, 2011. SSP June 2, 2011. SSP June 2, 2011. Collision of 2 Worlds. SSP June 2, 2011. Explosion of─. . Research. . Data. . Accrued Knowledge. Increased Requirements. A. Academic/Research Program. Extent of Lung Resection. No. of Subject. Event. Censored. Median Survival (95% CI). 60 mo Survival. Lobectomy. 1778. 616 (35%). 1162 (65%). NA (99.6, NA). 73.6% (71.4%, 75.6%). TAM (1µM). 72 hours. IL-1β levels. 48 hours. LPS (1µM). 0. A. NLRP3i (400μM. ). B. Supplemental Figure 4. Effect of the NLRP3 inflammasome inhibitor on IL‑1β production in bone marrow derived macrophages (BMDM) from genetically modified mice with constitutively active NLRP3.. Data source: . Wang R, Pan Y, Li C, et al. Analysis of major known driver mutations and prognosis in resected . adenosquamous. lung carcinomas. J . Thorac. . Oncol. . 2014;9:760-8. . Kohno T, . Nakaoku. Figure . S1. . . (A) . Schematic shows the three KREN1, KREN2, and KREN3 ~20S editosomes, and their protein interactions identified by yeast two-hybrid and co-expression studies (dashed lines) (Schnaufer et al. 2003; Schnaufer et al. 2010; Mehta et al. 2015). (B-D) Networks show detailed editosome architecture revealed by cross-linking and mass spectrometry (CXMS) (McDermott et al. 2016). Network edge widths are proportional to the number of interlinks observed between two proteins. All previously described interactions between editosome proteins were found in our cross-linking data. . children . aged 2–5 years . with employer-sponsored insurance receiving . clinical care for . attention-deficit/hyperactivity disorder (ADHD): United States, 2014. SUPPLEMENTAL FIGURE 2.. . Percentage of . Annals of Family Medicine . Supplemental materials for: Kimball S, Maju M, Singh N, Sonis L. Embedding an immigration legal navigator in a primary care clinic. Ann Fam Med . 2019;17(2): 177 . Cover L Supplemental Figure 1 Supplemental Figure 2 Supplemental Figure 3 Supplemental Figure 4 Supplemental Table 1 Supplemental Figure 5 CD44. GM130. CD40. MSCs. EVs. B. C. Supplemental Figure 1. Supplemental Figure 2. Supplemental Figure 3 . Supplemental Figure 4. A. B. A. B. C. Supplemental Figure 5. D. SSC. CD206. CD206. 25.7%. 14%. 1. 5. 10. 30. 50. 100. SP600125. 0,1. 1. 2. 5. 10. 20. ER-27319. 1. 5. 10. 30. 50. 100. Inhibitors concentration (µM). A. B. Supplemental Figure 1: B cell survival (A) . B cells were pre-treated with kinase inhibitors (GF109203 (PKC. 3. Table 1. . Significance level of comparison of absolute sweat rates for all regions measured at exercise intensity 1, uncorrected for multiple comparisons. . Supplemental Digital Content . 3. Table . A.. B.. Supplemental Figure 3. Control. α-synuclein. Vehicle. Nicotine. A.. B.. C.. D.. No RNAi. SV2L1 KD. SV2L2 KD. Scale bar: 10nm. 9.5nm. 14.7nm. Average diameter:. A. B. Supplemental figure 2. ELISA using FT and GnH-FT as antigens. A. B. * P <0.05, ** P<0.01, *** P<0.001, and **** P<0.00001. **. *. *. Top layer. Bottom layer. PDMS rod. +. cells. Nuclei. F-actin. Supplemental Figure 1: Lung Endothelial MPS. A.. B.. Supplemental Figure 1: A) Schematic of lung endothelial MPS. B) Imaging demonstrating coverage with endothelial cells prior to incubation of plasma in the lumens..

Download Document

Here is the link to download the presentation.
"Supplemental figure 1 PD-L2 ("The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents